Generics to Otezla (apremilast, Amgen), which is used to treat psoriatic arthritis and psoriasis, will be reimbursed starting January 2025. The ceiling price has been set as KRW 5,840 per tablet.

According to industry sources on December 20, Dong-A ST's 'Otelia,' Daeowoong Pharmaceutical's 'Apsola,' Chong Kun Dang's 'Otebell,' Dongkoo Bio's 'Otemila,' and Hanlim Pharm's 'Psopre Tab' as two tablets per package will all be listed for reimbursement.

The ceiling price has been set as KRW 5,840 per tablet. The 27-tablet package will cost KRW 141,328. The drug prices are the same for all five companies.

Otezla received approval from the Ministry of Food and Drug Safety (MFDS) i